Market Updates

Xymogen and Acasti Pharma Launch LipiChol540

Xymogen, Orlando, FL, has announced an exclusive partnership with Acasti Pharma, Québec, Canada, the biopharmaceutical company with whom they will launch the distribution of LipiChol540, a physician-prescribed medical food to manage omega 3 phospholipid deficiency. The formula will be distributed by Pharmaceutix Medical Foods, a wholly owned subsidiary of Xymogen. LipiChol540 is the only medical krill oil product in the world. It is pharmaceutically formulated to provide a stronger dosage and lower pill burden, compared to popular fish oil supplements, without the typical unpleasant taste or burping side effects.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters